Bath & Body Works (NYSE:BBWI) Price Target Raised to $24.00

Bath & Body Works (NYSE:BBWI) had its price objective lifted by JPMorgan Chase & Co. from $22.00 to $24.00 in a research report released on Tuesday morning,Benzinga reports. The firm currently has a neutral rating on the stock.

A number of other analysts have also recently commented on the company. Piper Sandler initiated coverage on Bath & Body Works in a research report on Friday, May 15th. They issued a “neutral” rating and a $20.00 price objective for the company. Weiss Ratings upgraded Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 9th. Barclays cut their price target on shares of Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a report on Thursday, May 28th. UBS Group reduced their price objective on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, May 20th. Finally, Jefferies Financial Group increased their price objective on shares of Bath & Body Works from $22.00 to $23.00 and gave the company a “hold” rating in a report on Tuesday, July 28th. Four analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $22.57.

Bath & Body Works Stock Down 0.6%

NYSE:BBWI opened at $19.56 on Tuesday. Bath & Body Works has a 52 week low of $14.27 and a 52 week high of $32.32. The stock has a market capitalization of $3.94 billion, a PE ratio of 5.49, a price-to-earnings-growth ratio of 1.94 and a beta of 1.38. The stock’s 50-day moving average price is $20.47 and its 200-day moving average price is $20.10.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.03. The firm had revenue of $1.38 billion during the quarter, compared to analyst estimates of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.Bath & Body Works’s revenue for the quarter was down 3.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.49 EPS. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Sell-side analysts expect that Bath & Body Works will post 2.63 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, September 4th. Shareholders of record on Friday, August 21st will be paid a $0.20 dividend. The ex-dividend date of this dividend is Friday, August 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.1%. Bath & Body Works’s dividend payout ratio (DPR) is 22.47%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. BlackRock Inc. acquired a new stake in Bath & Body Works during the second quarter worth about $449,065,000. AQR Capital Management LLC boosted its holdings in Bath & Body Works by 132.5% in the 4th quarter. AQR Capital Management LLC now owns 11,445,928 shares of the company’s stock valued at $229,834,000 after purchasing an additional 6,523,960 shares during the last quarter. Alliancebernstein L.P. boosted its holdings in Bath & Body Works by 5.8% in the 2nd quarter. Alliancebernstein L.P. now owns 5,737,796 shares of the company’s stock valued at $171,904,000 after purchasing an additional 315,738 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Bath & Body Works by 2.9% in the 4th quarter. Geode Capital Management LLC now owns 3,960,475 shares of the company’s stock valued at $79,542,000 after purchasing an additional 110,602 shares during the last quarter. Finally, Bank of America Corp DE grew its stake in shares of Bath & Body Works by 86.9% in the 3rd quarter. Bank of America Corp DE now owns 3,399,390 shares of the company’s stock valued at $87,568,000 after buying an additional 1,580,176 shares during the period. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.